antitrust

After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Thu, 05/25/23 - 01:10 pm
Gilead Sciences
Teva Pharmaceutical
legal
HIV
antitrust
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Mon, 05/15/23 - 11:19 am
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
Fierce Pharma
Fri, 04/21/23 - 10:20 am
Merck
Glenmark
Zetia
pay-for-delay
antitrust
legal
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
Tue, 04/11/23 - 11:46 am
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Viatris maintains legal winning streak with yet another EpiPen antitrust victory
Fierce Pharma
Mon, 04/3/23 - 10:51 pm
Viatris
EpiPen
Mylan
legal
antitrust
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
Endpoints
Mon, 03/20/23 - 09:50 am
JNJ
legal
Remicade
antitrust
biosimilars
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
Tue, 03/14/23 - 06:28 pm
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Fri, 02/24/23 - 08:55 am
Amarin
Hikma
legal
antitrust
generics
Vascepa
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Fierce Pharma
Wed, 02/22/23 - 06:54 pm
Gilead Sciences
legal
HIV
antitrust
Teva Pharmaceutical
JNJ
Novartis, Roche avoid $475M antitrust fine in French appeals court
Fierce Pharma
Mon, 02/20/23 - 12:57 pm
Novartis
Roche
antitrust
Lucentis
Illumina Could Face Hefty Fine Over Grail Acquisition
Medical Devices and Diagnostics Industry
Mon, 01/16/23 - 11:07 am
Illumina
Grail
M&A
antitrust
Europe
diagnostics
Medtech
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Reuters
Thu, 01/5/23 - 09:57 am
Novartis
generics
antitrust
legal
Exforge
hypertension
Is CVS' Acquisition of Signify in Danger of Falling Through?
Motley Fool
Thu, 09/15/22 - 10:32 am
CVS
Signify Health
M&A
antitrust
Illumina defeats F.T.C. in major antitrust case
NY Times, NY
Thu, 09/1/22 - 07:46 pm
Illumina
FTC
Grail
M&A
antitrust
After delay, CSL's $11.7B deal for Vifor poised to close next week
Fierce Pharma
Tue, 08/2/22 - 10:39 am
M&A
CSL
Vifor
antitrust
Can Illumina Hold on to Grail?
Medical Devices and Diagnostics Industry
Tue, 08/2/22 - 12:01 am
Illumina
Grail
M&A
Europe
antitrust
Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug
Fierce Pharma
Thu, 07/21/22 - 09:38 pm
Pfizer
Flynn Pharma
antitrust
drug pricing
Epanutin

Pages